C1-INH-HAE
Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency
13
Glucocorticoid receptor gene polymorphisms in hereditary angioedema with C1-inhibitor deficiency
8
Frequency of the virilising effects of attenuated androgens reported by women with hereditary angioedema
5
The physician and hereditary angioedema friend or foe: 62-year diagnostic delay and iatrogenic procedures
6
Serum fetuin-A, tumor necrosis factor alpha and C-reactive protein concentrations in patients with hereditary angioedema with C1-inhibitor deficiency
6
Emotional processes and stress in children affected by hereditary angioedema with C1-inhibitor deficiency: a multicenter, prospective study
8
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy
6
Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey
8
Cinryze™ as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety
8
Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study
10
Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiency
8
The effect of long-term danazol treatment on haematological parameters in hereditary angioedema
7
C1-INH and the contact system in COVID-19-associated coagulopathy
11
Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema
13
Nine year follow-up of a rare case of angioedema due to acquired C1-inhibitor deficiency with late onset and good response to attenuated androgen
5
Allergic diseases in the elderly
10
Practicalities of a reduced volume formulation of a C1-INH concentrate for the treatment of hereditary angioedema: real-life experience
7
Management of upper airway edema caused by hereditary angioedema
8
Mechanism of Action of Anti-C1-Inhibitor Autoantibodies: Prevention of the Formation of Stable C1s-C1-inh Complexes
10
Management of Hereditary Angioedema in Pediatric Patients
12